Francisco M Marty

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi request reprint Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin
    Francisco M Marty
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, MA 02115, USA
    Clin Infect Dis 41:e5-8. 2005
  2. doi request reprint CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation
    Francisco M Marty
    Division of Infectious Diseases, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, MA 02115, USA
    N Engl J Med 369:1227-36. 2013
  3. ncbi request reprint Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study
    Francisco M Marty
    Division of Infectious Diseases and Hematopoietic Stem Cell Transpalntation Service, Brigham and Women s Hospital and Dana Farber Cancer Instiute, Harvard Medical School, Boston, MA 02115, USA
    Blood 102:2768-76. 2003
  4. pmc Reactivity of (1-->3)-beta-d-glucan assay with commonly used intravenous antimicrobials
    Francisco M Marty
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, MA 02115, USA
    Antimicrob Agents Chemother 50:3450-3. 2006
  5. doi request reprint Role of (1-->3)-beta-D-glucan in the diagnosis of invasive aspergillosis
    Francisco M Marty
    Division of Infectious Diseases, Brigham and Women s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA
    Med Mycol 47:S233-40. 2009
  6. ncbi request reprint Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation
    Francisco M Marty
    Division of Infectious Diseases, Brigham and Women s Hospital, and Harvard Medical School, Boston, Massachusetts 02115, USA
    Biol Blood Marrow Transplant 12:552-9. 2006
  7. pmc Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis
    Francisco M Marty
    Division of Infectious Diseases, Brigham and Women s Hospital, 75 Francis Street, PBB A4, Boston, MA 02115, USA
    J Clin Microbiol 44:595-7. 2006
  8. doi request reprint Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial
    Francisco M Marty
    Brigham and Women s Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA
    Lancet Infect Dis 11:284-92. 2011
  9. doi request reprint Invasive fungal disease after remote inoculation in transplant recipients
    Francisco M Marty
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Clin Infect Dis 52:e7-10. 2011
  10. pmc Disseminated trichosporonosis caused by Trichosporon loubieri
    Francisco M Marty
    Division of Infectious Diseases, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Clin Microbiol 41:5317-20. 2003

Detail Information

Publications57

  1. ncbi request reprint Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin
    Francisco M Marty
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, MA 02115, USA
    Clin Infect Dis 41:e5-8. 2005
    ..To our knowledge, ivermectin levels are reported for the first time in this situation...
  2. doi request reprint CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation
    Francisco M Marty
    Division of Infectious Diseases, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, MA 02115, USA
    N Engl J Med 369:1227-36. 2013
    ..CMX001 has potent in vitro activity against CMV and other double-stranded DNA viruses. We evaluated the safety and anti-CMV activity of CMX001 in patients who had undergone allogeneic hematopoietic-cell transplantation...
  3. ncbi request reprint Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study
    Francisco M Marty
    Division of Infectious Diseases and Hematopoietic Stem Cell Transpalntation Service, Brigham and Women s Hospital and Dana Farber Cancer Instiute, Harvard Medical School, Boston, MA 02115, USA
    Blood 102:2768-76. 2003
    ..Pre-emptive systemic antifungal therapy against molds should be considered in patients who develop severe GVHD after HSCT if infliximab is used...
  4. pmc Reactivity of (1-->3)-beta-d-glucan assay with commonly used intravenous antimicrobials
    Francisco M Marty
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, MA 02115, USA
    Antimicrob Agents Chemother 50:3450-3. 2006
    ..False-positive BG assays may occur when some antimicrobials are administered; however, this needs to be confirmed...
  5. doi request reprint Role of (1-->3)-beta-D-glucan in the diagnosis of invasive aspergillosis
    Francisco M Marty
    Division of Infectious Diseases, Brigham and Women s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA
    Med Mycol 47:S233-40. 2009
    ..Factors affecting the production and clearance of BG during IA and other IFD need additional study to further refine its diagnostic utility...
  6. ncbi request reprint Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation
    Francisco M Marty
    Division of Infectious Diseases, Brigham and Women s Hospital, and Harvard Medical School, Boston, Massachusetts 02115, USA
    Biol Blood Marrow Transplant 12:552-9. 2006
    ..Sirolimus and voriconazole may be safely coadministered if there is an empiric initial 90% sirolimus dose reduction combined with systematic monitoring of trough levels...
  7. pmc Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis
    Francisco M Marty
    Division of Infectious Diseases, Brigham and Women s Hospital, 75 Francis Street, PBB A4, Boston, MA 02115, USA
    J Clin Microbiol 44:595-7. 2006
    ..The breakthrough isolate was indistinguishable from pretreatment daptomycin-susceptible isolates by pulsed-field gel electrophoresis. Daptomycin nonsusceptibility was confirmed by MIC and time-kill curve analyses...
  8. doi request reprint Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial
    Francisco M Marty
    Brigham and Women s Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA
    Lancet Infect Dis 11:284-92. 2011
    ..We assessed the safety, tolerability, and antiviral activity of oral maribavir in such patients...
  9. doi request reprint Invasive fungal disease after remote inoculation in transplant recipients
    Francisco M Marty
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Clin Infect Dis 52:e7-10. 2011
    ..Invasive fungal disease resulting from remote inoculation is a distinct syndrome in immunocompromised patients presenting with soft-tissue abnormalities in areas of prior trauma...
  10. pmc Disseminated trichosporonosis caused by Trichosporon loubieri
    Francisco M Marty
    Division of Infectious Diseases, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Clin Microbiol 41:5317-20. 2003
    ..Trichosporonosis is an emerging invasive fungal infection in immunosuppressed patients; a case of disseminated infection caused by Trichosporon loubieri presented confirms its role as a human pathogen...
  11. pmc Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis
    Francisco M Marty
    Division of Infectious Diseases, Boston, MA 02115, USA
    Blood 110:490-500. 2007
    ..66; P = .14 and P = .35, respectively). The protective effect of sirolimus-containing GVHD prophylaxis regimens on CMV reactivation should be confirmed in randomized trials...
  12. doi request reprint Safety of posaconazole and sirolimus coadministration in allogeneic hematopoietic stem cell transplants
    David W Kubiak
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Biol Blood Marrow Transplant 18:1462-5. 2012
    ..Concurrent sirolimus and posaconazole use seems to be well tolerated with a 33% to 50% empiric sirolimus dose reduction and close monitoring of serum sirolimus trough levels at the time of posaconazole initiation...
  13. pmc Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis
    Joshua A Hill
    Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Biol Blood Marrow Transplant 18:1638-48. 2012
    ..1-17.3; P = .04). Death from HHV-6-PALE occurred in 50% of affected patients undergoing UCBT and no recipients of adult-donor cells. Patients receiving UCBT have increased risk for HHV-6-PALE and greater morbidity from this disease...
  14. doi request reprint A targeted peritransplant antifungal strategy for the prevention of invasive fungal disease after lung transplantation: a sequential cohort analysis
    Sophia Koo
    Division of Infectious Diseases, Department of Medicine, Brigham and Women s Hospital, Boston, MA 02115, USA
    Transplantation 94:281-6. 2012
    ....
  15. pmc Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome
    Ami S Bhatt
    Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA
    N Engl J Med 369:517-28. 2013
    ..It has been hypothesized that the cord colitis syndrome, a complication of umbilical-cord hematopoietic stem-cell transplantation, is infectious in origin...
  16. pmc Serum galactomannan and (1->3)-β-D-glucan assays for patients with multiple myeloma and Waldenstrom's macroglobulinemia
    Nicolas C Issa
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts, USA
    J Clin Microbiol 50:1054-6. 2012
    ..1→3)-β-d-glucan assay results were uninterpretable in 24% of patients. Patients with IgG levels of >2,000 mg/dl had higher odds of uninterpretable (1→3)-β-d-glucan results...
  17. doi request reprint How do we manage oral infections in allogeneic stem cell transplantation and other severely immunocompromised patients?
    Stefan Palmason
    Division of Oral Medicine and Dentistry, Brigham and Women s Hospital, 1620 Tremont Street, Boston, MA 02120, USA
    Oral Maxillofac Surg Clin North Am 23:579-99, vii. 2011
    ..This article discusses the current knowledge of the most frequent presentations of infections in this patient population and reviews contemporary approaches to prevention, diagnosis, and management...
  18. pmc Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients
    Nicolas C Issa
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Biol Blood Marrow Transplant 17:434-8. 2011
    ..11; 95% confidence interval, 0.01-0.97). The vaccine was safe and well tolerated. Strategies are needed to improve the influenza vaccine response in this population, especially those receiving immunotherapy...
  19. doi request reprint Cord colitis syndrome in cord-blood stem-cell transplantation
    Alex F Herrera
    Department of Medicine, Brigham and Women s Hospital, 75 Francis St, Boston, MA 02115, USA
    N Engl J Med 365:815-24. 2011
    ..After the transplantation and engraftment of hematopoietic stem cells from umbilical-cord blood, we observed a new syndrome of culture-negative, antibiotic-responsive diarrhea not attributable to any known cause...
  20. doi request reprint Invasive fungal disease in patients treated for newly diagnosed acute leukemia
    Sarah P Hammond
    Division of Infectious Diseases, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
    Am J Hematol 85:695-9. 2010
    ..52, 15.4). Those patients with more days of neutropenia in the first 100 days after AL diagnosis, such as those who did not achieve remission after a first course of induction chemotherapy, were more likely to develop IFD...
  21. pmc Respiratory virus detection in immunocompromised patients with FilmArray respiratory panel compared to conventional methods
    Sarah P Hammond
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, MA, USA
    J Clin Microbiol 50:3216-21. 2012
    ..The FilmArray respiratory panel assay allowed for increased identification of respiratory viral pathogens in this cohort of immunocompromised patients...
  22. pmc Mortality in hematologic malignancy and hematopoietic stem cell transplant patients with mucormycosis, 2001 to 2009
    Sarah P Hammond
    Division of Infectious Diseases, Brigham and Women s Hospital, Dana Farber Cancer Institute, and Harvard Medical School, Boston, Massachusetts 02115, USA
    Antimicrob Agents Chemother 55:5018-21. 2011
    ..04]), as did 12-week mortality (78% in 2001 to 2003 versus 55% in 2004 to 2006 versus 20% in 2007 to 2009 [P = 0.01])...
  23. doi request reprint Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation
    Sarah P Hammond
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Biol Blood Marrow Transplant 15:1049-59. 2009
    ..In this cohort, HBV reactivation often developed in patients with cGVHD. Liver biopsy was useful in those patients with both to delineate the contribution of each to liver dysfunction...
  24. pmc Molecular methods to improve diagnosis and identification of mucormycosis
    Sarah P Hammond
    Division of Infectious Diseases, Brigham and Women s Hospital, Dana Farber Cancer Institute, and Harvard Medical School, 4 Boston, Massachusetts 02115, USA
    J Clin Microbiol 49:2151-3. 2011
    ..Mucorales PCR is useful for confirmation of the diagnosis of mucormycosis and for further characterization of the infection in cases where cultures are negative...
  25. doi request reprint Fonsecaea monophora cerebral phaeohyphomycosis: case report of successful surgical excision and voriconazole treatment and review
    Sophia Koo
    Division of Infectious Diseases, Brigham and Women s Hospital, 75 Francis Street, PBB A4, Boston, MA 02115, USA
    Med Mycol 48:769-74. 2010
    ..She discontinued antifungal therapy after an 18-month treatment course, and has remained free of any clinical or radiographic evidence of recurrent abscess formation three years later...
  26. doi request reprint Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis
    David W Kubiak
    Division of Infectious Diseases and Department of Pharmacy, Brigham and Women s Hospital, Boston, Massachusetts 02115 6110, USA
    Clin Ther 32:637-48. 2010
    ..Caspofungin is approved in the United States for empiric antifungal therapy for persistent febrile neutropenia (FN). There are limited data about the use of other echinocandins in this setting...
  27. doi request reprint BK virus disease after allogeneic stem cell transplantation: a cohort analysis
    Nienke M G Rorije
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts University of Groningen Medical School, Groningen, The Netherlands
    Biol Blood Marrow Transplant 20:564-70. 2014
    ..Prospective studies are needed to better define the morbidity of post-HSCT BKV disease and inform the design of prophylaxis and treatment trials. ..
  28. ncbi request reprint Maribavir and human cytomegalovirus-what happened in the clinical trials and why might the drug have failed?
    Francisco M Marty
    Brigham and Women s Hospital, Harvard Medical School, United States
    Curr Opin Virol 1:555-62. 2011
    ..We discuss key aspects of study design that should be considered in the study of new interventions needed to advance the prevention and treatment of CMV in transplant recipients...
  29. doi request reprint Invasive Mycoleptodiscus fungal cellulitis and myositis
    Sophia Koo
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, MA 02115, USA
    Med Mycol 50:740-5. 2012
    ..This is the first case of Mycoleptodiscus invasive fungal disease in which the causative agent could not be resolved at the species level because of inconsistencies between morphological and molecular data...
  30. pmc Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions
    Timothy J Henrich
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts, USA
    J Infect Dis 202:1478-81. 2010
    ..XMRV DNA was not detected in any participant samples. We found no association between XMRV and patients with chronic fatigue syndrome or chronic immunomodulatory conditions...
  31. pmc Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosis
    Sophia Koo
    Division of Infectious Diseases, Brigham and Women s Hospital, 75 Francis Street, PBB A4, Boston, MA 02115, USA
    J Clin Microbiol 48:1255-60. 2010
    ....
  32. doi request reprint Diagnostic performance of the (1-->3)-beta-D-glucan assay for invasive fungal disease
    Sophia Koo
    Brigham and Women s Hospital, Dana Farber Cancer Institute, Harvard Medical School, and 4Harvard School of Public Health, Boston, Massachusetts 02115, USA
    Clin Infect Dis 49:1650-9. 2009
    ..The (1-->3)-beta-D-glucan (BG) assay may be a useful adjunct, but its diagnostic performance is not well characterized...
  33. doi request reprint Live attenuated varicella-zoster vaccine in hematopoietic stem cell transplantation recipients
    Nicolas C Issa
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts Harvard Medical School, Boston, Massachusetts Electronic address
    Biol Blood Marrow Transplant 20:285-7. 2014
    ..Live attenuated zoster vaccine appears generally safe in this population when vaccinated as noted; the overall vaccination risk needs to be weighed against the risk of wild-type VZV disease in this high-risk population. ..
  34. doi request reprint Postoperative antibacterial prophylaxis for the prevention of infectious complications associated with tube thoracostomy in patients undergoing elective general thoracic surgery: a double-blind, placebo-controlled, randomized trial
    David A Oxman
    Divisions of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts, USA
    JAMA Surg 148:440-6. 2013
    ..To determine whether extended postoperative antibacterial prophylaxis for patients undergoing elective thoracic surgery with tube thoracostomy reduces the risk of infectious complications compared with preoperative prophylaxis only...
  35. ncbi request reprint Infectious complications associated with alemtuzumab use for lymphoproliferative disorders
    Stanley I Martin
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Clin Infect Dis 43:16-24. 2006
    ..Alemtuzumab is an emerging therapy for refractory lymphoproliferative disorders. The associated long-term risks of infection remain poorly defined...
  36. ncbi request reprint Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole
    Subroto Paul
    Division of Thoracic Surgery, and Department of Surgery, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Ann Thorac Surg 82:338-40. 2006
    ..The current report demonstrates successful treatment, even in the setting of subsequent bone marrow transplantation and immunosuppression, using a combination of surgical resection and posaconazole therapy...
  37. ncbi request reprint Management of oral infections in cancer patients
    Mark A Lerman
    Division of Oral Medicine and Dentistry, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
    Dent Clin North Am 52:129-53, ix. 2008
    ..With the majority of cancer patients treated as outpatients in the community setting, oral health care professionals play an important role in managing such infectious complications of cancer therapy...
  38. pmc Isavuconazole treatment of a patient with disseminated mucormycosis
    Driele Peixoto
    Division of Infectious Diseases, Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts, USA
    J Clin Microbiol 52:1016-9. 2014
    ..miehei involving lung, brain, and skin. After failing posaconazole and being intolerant to amphotericin, he was treated effectively with isavuconazole for over 6 months despite ongoing treatment for relapsed leukemia. ..
  39. pmc Adjunctive management of central line-associated bloodstream infections with 70% ethanol-lock therapy
    David W Kubiak
    Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
    J Antimicrob Chemother 69:1665-8. 2014
    ..We evaluated the safety and potential efficacy of 70% ELT for CLABSI at our institution after implementation of a hospital ELT protocol...
  40. doi request reprint Treatment of parainfluenza 3 infection with DAS181 in a patient after allogeneic stem cell transplantation
    Yi Bin Chen
    Bone Marrow Transplant Unit, Massachusetts General Hospital, Boston, MA, USA
    Clin Infect Dis 53:e77-80. 2011
    ..Symptoms, oxygenation, and pulmonary function tests improved. Nasopharyngeal samples showed a reduction in viral load. DAS181 should be systematically evaluated for severe PIV infection...
  41. doi request reprint Infectious granulomatous dermatitis associated with Rothia mucilaginosa bacteremia: A case report
    Elizabeth A Morgan
    Department of Pathology, Brigham and Women s Hospital, Boston, MA, USA
    Am J Dermatopathol 32:175-9. 2010
    ..mucilaginosa bacteremia and raises awareness of this unusual histopathological presentation in the setting of a bacterial infection affecting the skin...
  42. doi request reprint Infectious complications associated with immunomodulating biologic agents
    Sophia Koo
    Division of Infectious Diseases, Brigham and Women s Hospital, 75 Francis Street, PBB A4, Boston, MA 02115, USA
    Infect Dis Clin North Am 24:285-306. 2010
    ..This review describes the spectrum of infectious complications associated to date with each of the immunomodulating biologic therapies approved by the US Food and Drug Administration...
  43. pmc Gordonia bronchialis bacteremia and pleural infection: case report and review of the literature
    Jennifer A Johnson
    Division of Infectious Diseases, Department of Pathology, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    J Clin Microbiol 49:1662-6. 2011
    ..We describe a case of Gordonia bronchialis bacteremia and pleural space infection in the absence of an indwelling intravascular catheter and review the breadth of reported infections with this emerging pathogen...
  44. pmc Safety and pharmacokinetics of intravenous zanamivir treatment in hospitalized adults with influenza: an open-label, multicenter, single-arm, phase II study
    Francisco M Marty
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts
    J Infect Dis 209:542-50. 2014
    ..Intravenous zanamivir is a neuraminidase inhibitor suitable for treatment of hospitalized patients with severe influenza...
  45. ncbi request reprint The prevention of infection post-transplant: the role of prophylaxis, preemptive and empiric therapy
    Francisco M Marty
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, MA 02115, USA
    Transpl Int 19:2-11. 2006
    ..This review provides a conceptual framework to approach the risk and risk periods for infection in solid organ and hematopoietic stem cell transplant recipients as well as an approach to antimicrobial use in this population...
  46. doi request reprint Persistent and relapsing babesiosis in immunocompromised patients
    Peter J Krause
    Division of Infectious Diseases, Connecticut Children s Medical Center, and Department of Pediatrics, University of Connecticut School of Medicine, Farmington, Connecticut 06106, USA
    Clin Infect Dis 46:370-6. 2008
    ..Although patients experiencing babesiosis that is unresponsive to standard antimicrobial therapy have been described, the pathogenesis, clinical course, and optimal treatment regimen of such cases remain uncertain...
  47. ncbi request reprint Infectious complications associated with immunomodulating biologic agents
    Sophia Koo
    Division of Infectious Diseases, Brigham and Women s Hospital, 75 Francis Street, PBB A4, Boston, MA 02115, USA Division of Infectious Diseases, Dana Farber Cancer Institute, Boston, MA, USA Harvard Medical School, Boston, MA, USA
    Hematol Oncol Clin North Am 25:117-38. 2011
    ..This review describes the spectrum of infectious complications associated to date with each of the immunomodulating biologic therapies approved by the US Food and Drug Administration...
  48. pmc Recovery of Herbaspirillum species from persons with cystic fibrosis
    Theodore Spilker
    Division of Infectious Diseases, Department of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor, Michigan 48109 0646, USA
    J Clin Microbiol 46:2774-7. 2008
    ..Although the role that these species play in lung disease in persons with CF is not known, their differentiation from other species is important and has serious implications for clinical care and patient well-being...
  49. ncbi request reprint Diagnostic efficacy and safety of computed tomography-guided transthoracic needle biopsy in patients with hematologic malignancies
    Marije H Kallenberg
    Division of Infectious Diseases, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
    Acad Radiol 16:1408-15. 2009
    ..Hence, the diagnostic efficacy and safety of computed tomography-guided TTNB were retrospectively evaluated in this population...
  50. ncbi request reprint Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?
    David A Oxman
    Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA
    J Antimicrob Chemother 65:1460-5. 2010
    ..Candidaemia is often treated with fluconazole in the absence of susceptibility testing. We examined factors associated with candidaemia caused by Candida isolates with reduced susceptibility to fluconazole...
  51. doi request reprint Cost analysis of dental services needed before hematopoietic cell transplantation
    Hani Mawardi
    Attending Physician, Division of Oral Medicine and Dentistry, Brigham and Women s Hospital, Boston, MA, USA Assistant Professor, Department of Oral Basic and Clinical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia Electronic address
    Oral Surg Oral Med Oral Pathol Oral Radiol 117:59-66. 2014
    ..The objective of this study was to determine the type, number, and costs of pre-transplantation dental procedures in this population...
  52. ncbi request reprint Lyme meningoradiculitis and myositis after allogeneic hematopoietic stem cell transplantation
    Martin Rodriguez
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Clin Infect Dis 41:e112-4. 2005
    ..To our knowledge, this is the first report of such an infection occurring after allogeneic hematopoietic stem cell transplantation in the United States...
  53. ncbi request reprint Caspofungin versus liposomal amphotericin B for empirical therapy
    Francisco M Marty
    N Engl J Med 352:410-4; author reply 410-4. 2005
  54. ncbi request reprint Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants
    Francisco M Marty
    N Engl J Med 350:950-2. 2004
  55. ncbi request reprint (1->3)beta-D-glucan assay positivity in patients with Pneumocystis (carinii) jiroveci pneumonia
    Francisco M Marty
    Ann Intern Med 147:70-2. 2007
  56. ncbi request reprint Posaconazole for invasive aspergillosis?
    Lindsey R Baden
    Clin Infect Dis 45:664; author reply 665-6. 2007
  57. ncbi request reprint Transmission of lymphocytic choriomeningitis virus by organ transplantation
    Staci A Fischer
    Rhode Island Hospital and Brown Medical School, Providence, USA
    N Engl J Med 354:2235-49. 2006
    ..Each cluster was investigated because diagnostic evaluations were unrevealing, and in each a common donor was recognized...